Publicacións en colaboración con investigadores/as de University of Michigan–Ann Arbor (2)

2020

  1. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    The Lancet, Vol. 396, Núm. 10253, pp. 759-769

2019

  1. Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients

    Journal of Cellular and Molecular Medicine, Vol. 23, Núm. 3, pp. 2125-2135